Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.051 | 0.4 |